Related Experiment Video

Updated: May 27, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Mitochondrial dysfunction and β-cell failure in type 2 diabetes mellitus

Zhongmin Alex Ma1, Zhengshan Zhao, John Turk

  • 1Division of Experimental Diabetes and Aging, Department of Geriatrics and Palliative Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA. zhongmin.ma@mssm.edu

Experimental Diabetes Research
|November 24, 2011
PubMed

Insights

Mitochondrial reactive oxygen species (ROS) contribute to pancreatic beta-cell failure in type 2 diabetes (T2DM). Protecting mitochondrial phospholipids from ROS may prevent or slow T2DM development.

Area of Science:

  • Endocrinology
  • Mitochondrial Biology
  • Diabetes Research

Background:

  • Type 2 diabetes mellitus (T2DM) involves insulin resistance and pancreatic beta-cell failure.
  • Mitochondrial dysfunction is a key factor in beta-cell failure during T2DM progression.
  • Reactive oxygen species (ROS) from beta-cell mitochondria activate stress pathways.

Purpose of the Study:

  • To elucidate mechanisms by which ROS impact mitochondrial structure and function, leading to beta-cell failure.
  • To investigate the role of ROS in regulating Uncoupling Protein 2 (UCP2) and ATP synthesis.
  • To examine the involvement of Group VIA phospholipase A2 (iPLA2β) in repairing mitochondrial phospholipids and its relation to T2DM.

Main Methods:

  • Focus on reviewing mechanisms of ROS action on beta-cell mitochondria.
  • Analysis of ROS-induced UCP2 activation and its effect on ATP synthesis.
  • Examination of ROS-mediated oxidation of mitochondrial phospholipids and its consequences.
  • Assessment of iPLA2β's role in mitochondrial phospholipid repair and T2DM susceptibility.

Main Results:

  • ROS activate UCP2, causing proton leak, reducing beta-cell ATP synthesis, and impairing insulin secretion.
  • ROS oxidize mitochondrial phospholipids, compromising membrane integrity and leading to apoptosis via cytochrome c release.
  • iPLA2β deficiency exacerbates ROS-induced mitochondrial injury and increases susceptibility to T2DM.

Conclusions:

  • Mitochondrial ROS play a critical role in beta-cell dysfunction and failure in T2DM.
  • Targeting ROS effects on mitochondrial phospholipids presents a potential therapeutic strategy for T2DM.
  • Preserving mitochondrial integrity through interventions against ROS damage may prevent or delay T2DM onset.

More Related Videos

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds12:32

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

Published on: January 23, 2018

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...